SIA IMUNOMA
Inactive
In 2023, SIA IMUNOMA had revenue of 200.9 thousand EUR and loss of 48.7 thousand EUR. The company has 1 employees.
Warning
Business activity is currently suspended
| year | 2023Latest | 2022 | 2021 |
|---|---|---|---|
Revenue | 200,9k € -39.5% | 331,9k € +5320.3% | 6,1k € -93.4% |
Profit | -48,7k € -269.2% | 28,8k € +3987.2% | 704 € -96.4% |
Assets | 77,7k € +12.8% | 68,9k € +144.7% | 28,1k € +7.9% |
Liabilities | 73,2k € +367.2% | 15,7k € +322.4% | 3,7k € +57.8% |
Equity | 4,5k € -91.5% | 53,2k € +117.7% | 24,4k € +3.0% |
Employees | 1 -93.3% | 15 +1400.0% | 1 -50.0% |
Overall rating | C49/100 |
Financial health | 40/100 |
Credit history | 70/100 |
Legal history | 70/100 |
Business activity | 5/100 |
| Overall risk | High |
Business activity is suspended | |
Possible tax debts | |
Negative profit | |
Regular report filing | |
SIA IMUNOMA is located at Rīga, Āgenskalna iela 24 - 1.
In 2023, SIA IMUNOMA had revenue of 200 861 EUR and loss of 48 688 EUR. Compared to previous year, revenue decreased by 39.5%. View full financial report →
In 2024, SIA IMUNOMA had an average of 1 employees. View tax history →
No, SIA IMUNOMA does not have an active VAT number and is not registered as a VAT payer.
In 2024, the average gross salary at SIA IMUNOMA was approximately 420,46 € per month (net ~ 376,31 €). This is an approximate calculation. View salary details →
SIA IMUNOMA was founded on November 26, 2019. The company has been operating for 7 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 7 years | 119 - 123 | 29% | |
Net revenue | 200 861,00 € | 43 - 47 | 71% | |
Profit | -48 688,00 € | 155 - 159 | 8% | |
Equity | 4526,00 € | 99 - 103 | 15% | |
Assets | 77 716,00 € | 68 - 72 | 56% | |
Liquidity | 1.06 | - | 40% | |
Profitability | -24.2% | - | 10% |
Liquidation process has been initiated.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Registered in the Latvian company register.